AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimitoss M Forte 4mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Minitoss Medicines

Salt Composition

Glimepiride (4mg) + Metformin (1000mg)

Overview Glimitoss M Forte 4mg/1000mg Tablet SR

Diabetac Duo 4mg/1000mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Administer Diabetac Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan involving diet, exercise, and weight control as directed by your doctor. Commonly, Diabetac Duo may cause hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to counter them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary foods, fruit juice). Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your physician of any history of heart problems before starting Diabetac Duo; its suitability may be affected. Pregnant or lactating individuals should consult their doctor prior to use. Regular blood sugar monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimitoss M Forte 4mg/1000mg Tablet SR

The provided text is "undefined," so no rewriting is possible.

Uses of Glimitoss M Forte 4mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimitoss M Forte 4mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimitoss M Forte 4mg/1000mg Sustained-Release tablets should be administered with a meal.

Common Side effects of Glimitoss M Forte 4mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimitoss M Forte 4mg/1000mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimitoss M Forte 4mg/1000mg Sustained-Release tablets with food.

How Glimitoss M Forte 4mg/1000mg Tablet SR works:

Glimepiride/Metformin 4mg/1000mg extended-release tablets (brand name: Glimitoss M Forte) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts triply: it decreases hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimitoss M Forte 4mg/1000mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimitoss M Forte 4mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimitoss M Forte 4mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimitoss M Forte 4mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glimitoss M Forte 4mg/1000mg SR tablets. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; however, this medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimitoss M Forte 4mg/1000mg Tablet SR :

Should you forget to take a Glimitoss M Forte 4mg/1000mg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimitoss M Forte 4mg/1000mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Glimitoss M Forte 4mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimitoss M Forte 4mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimitoss M Forte 4mg/1000mg Tablet SR and seek immediate medical attention.
Glimitoss M Forte 4mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glimitoss M Forte 4mg/1000mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimitoss M Forte 4mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimitoss M Forte 4mg/1000mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimitoss M Forte 4mg/1000mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimitoss M Forte 4mg/100...
73
MRP 85
14% off